A citation-based method for searching scientific literature

Jason Weatherald, Marie-Camille Chaumais, Laurent Savale, Xavier Jaïs, Andrei Seferian, Matthieu Canuet, Hélène Bouvaist, Pascal Magro, Anne Bergeron, Christophe Guignabert, Olivier Sitbon, Gérald Simonneau, Marc Humbert, David Montani. Eur Respir J 2017
Times Cited: 62







List of co-cited articles
1228 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pulmonary arterial hypertension in patients treated by dasatinib.
David Montani, Emmanuel Bergot, Sven Günther, Laurent Savale, Anne Bergeron, Arnaud Bourdin, Helene Bouvaist, Matthieu Canuet, Christophe Pison, Margareth Macro,[...]. Circulation 2012
393
59

Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension.
Christophe Guignabert, Carole Phan, Andrei Seferian, Alice Huertas, Ly Tu, Raphaël Thuillet, Caroline Sattler, Morane Le Hiress, Yuichi Tamura, Etienne-Marie Jutant,[...]. J Clin Invest 2016
159
56

Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
Gérald Simonneau, David Montani, David S Celermajer, Christopher P Denton, Michael A Gatzoulis, Michael Krowka, Paul G Williams, Rogerio Souza. Eur Respir J 2019
37

Clinical features of pulmonary arterial hypertension in patients receiving dasatinib.
Neil P Shah, Nicola Wallis, Harrison W Farber, Michael J Mauro, Robert A Wolf, Daniele Mattei, Mausumee Guha, Delphine Rea, Andrew Peacock. Am J Hematol 2015
76
33

Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity.
Marianne Riou, Andrei Seferian, Laurent Savale, Marie-Camille Chaumais, Christophe Guignabert, Matthieu Canuet, Pascal Magro, Delphine Rea, Olivier Sitbon, Xavier Jaïs,[...]. Eur Respir J 2016
31
51


Pulmonary hypertension associated with ponatinib therapy.
Fleur-Marie Quilot, Marjolaine Georges, Nicolas Favrolt, Guillaume Beltramo, Clément Foignot, Aurélie Grandvuillemin, David Montani, Philippe Bonniaud, Philippe Camus. Eur Respir J 2016
33
48

Bosutinib therapy resulting in severe deterioration of pre-existing pulmonary arterial hypertension.
Peter M Hickey, Alfred A R Thompson, Athanasios Charalampopoulos, Charles A Elliot, Neil Hamilton, David G Kiely, Allan Lawrie, Ian Sabroe, Robin Condliffe. Eur Respir J 2016
23
69

Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.
Marius M Hoeper, Robyn J Barst, Robert C Bourge, Jeremy Feldman, Adaani E Frost, Nazzareno Galié, Miguel Angel Gómez-Sánchez, Friedrich Grimminger, Ekkehard Grünig, Paul M Hassoun,[...]. Circulation 2013
372
24

Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial.
Jorge E Cortes, Giuseppe Saglio, Hagop M Kantarjian, Michele Baccarani, Jiří Mayer, Concepción Boqué, Neil P Shah, Charles Chuah, Luis Casanova, Brigid Bradley-Garelik,[...]. J Clin Oncol 2016
492
20

Src tyrosine kinase is crucial for potassium channel function in human pulmonary arteries.
Chandran Nagaraj, Bi Tang, Zoltán Bálint, Malgorzata Wygrecka, Andelko Hrzenjak, Grazyna Kwapiszewska, Elvira Stacher, Joerg Lindenmann, E Kenneth Weir, Horst Olschewski,[...]. Eur Respir J 2013
80
19


Pulmonary arterial hypertension induced by tyrosine kinase inhibitors.
Jason Weatherald, Marie-Camille Chaumais, David Montani. Curr Opin Pulm Med 2017
30
40

Pulmonary arterial hypertension associated with protein kinase inhibitors: a pharmacovigilance-pharmacodynamic study.
Lucie Cornet, Charles Khouri, Matthieu Roustit, Christophe Guignabert, Marie-Camille Chaumais, Marc Humbert, Bruno Revol, Fabien Despas, David Montani, Jean-Luc Cracowski. Eur Respir J 2019
29
37


Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension.
Roham T Zamanian, Haley Hedlin, Paul Greuenwald, David M Wilson, Joshua I Segal, Michelle Jorden, Kristina Kudelko, Juliana Liu, Andrew Hsi, Allyson Rupp,[...]. Am J Respir Crit Care Med 2018
49
20

A case of worsening pulmonary arterial hypertension and pleural effusions by bosutinib after prior treatment with dasatinib.
Karan Seegobin, Amit Babbar, Jason Ferreira, Brittany Lyons, James Cury, Vandana Seeram. Pulm Circ 2017
15
66

Elevation of pulmonary artery pressure as a complication of nilotinib therapy for chronic myeloid leukemia.
Dariusz Zakrzewski, Ilona Seferynska, Krzysztof Warzocha, Tomasz Hryniewiecki. Int J Hematol 2012
14
57

Pleural effusion in patients with chronic myelogenous leukemia treated with dasatinib after imatinib failure.
Alfonso Quintás-Cardama, Hagop Kantarjian, Susan O'brien, Gautham Borthakur, John Bruzzi, Reginald Munden, Jorge Cortes. J Clin Oncol 2007
267
12

First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension.
Cécile Daccord, Igor Letovanec, Patrick Yerly, Jonathan Bloch, Adam Ogna, Laurent P Nicod, John-David Aubert. Eur Respir J 2018
14
57

Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.
Giuseppe Saglio, Dong-Wook Kim, Surapol Issaragrisil, Philipp le Coutre, Gabriel Etienne, Clarisse Lobo, Ricardo Pasquini, Richard E Clark, Andreas Hochhaus, Timothy P Hughes,[...]. N Engl J Med 2010
11

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.
Michele Baccarani, Michael W Deininger, Gianantonio Rosti, Andreas Hochhaus, Simona Soverini, Jane F Apperley, Francisco Cervantes, Richard E Clark, Jorge E Cortes, François Guilhot,[...]. Blood 2013
11

Pulmonary hypertension associated with benfluorex exposure.
Laurent Savale, Marie-Camille Chaumais, Vincent Cottin, Emmanuel Bergot, Irène Frachon, Grégoire Prevot, Christophe Pison, Claire Dromer, Patrice Poubeau, Nicolas Lamblin,[...]. Eur Respir J 2012
53
13

Pulmonary arterial hypertension in France: results from a national registry.
Marc Humbert, Olivier Sitbon, Ari Chaouat, Michèle Bertocchi, Gilbert Habib, Virginie Gressin, Azzedine Yaici, Emmanuel Weitzenblum, Jean-François Cordier, François Chabot,[...]. Am J Respir Crit Care Med 2006
11

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.
Olivier Sitbon, Marc Humbert, Xavier Jaïs, Vincent Ioos, Abdul M Hamid, Steeve Provencher, Gilles Garcia, Florence Parent, Philippe Hervé, Gérald Simonneau. Circulation 2005
701
11

Dasatinib increases endothelial permeability leading to pleural effusion.
Carole Phan, Etienne-Marie Jutant, Ly Tu, Raphaël Thuillet, Andrei Seferian, David Montani, Alice Huertas, Jan van Bezu, Fabian Breijer, Anton Vonk Noordegraaf,[...]. Eur Respir J 2018
33
21

Development of pulmonary arterial hypertension during oral dasatinib therapy for chronic myelogenous leukemia.
Sakura Morishita, Maki Hagihara, Megumi Itabashi, Yoshimi Ishii, Wataru Yamamoto, Ayumi Numata, Kenji Motohashi, Kenji Matsumoto, Shin Fujisawa, Hideaki Nakajima. Rinsho Ketsueki 2016
11
54

Pulmonary veno-occlusive disease.
David Montani, Edmund M Lau, Peter Dorfmüller, Barbara Girerd, Xavier Jaïs, Laurent Savale, Frederic Perros, Esther Nossent, Gilles Garcia, Florence Parent,[...]. Eur Respir J 2016
130
9

An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.
Raymond L Benza, Dave P Miller, Robyn J Barst, David B Badesch, Adaani E Frost, Michael D McGoon. Chest 2012
654
9


Pulmonary arterial hypertension in patients treated with interferon.
Laurent Savale, Caroline Sattler, Sven Günther, David Montani, Marie-Camille Chaumais, Swanny Perrin, Xavier Jaïs, Andrei Seferian, Roland Jovan, Sophie Bulifon,[...]. Eur Respir J 2014
66
9

Chemotherapy-induced pulmonary hypertension: role of alkylating agents.
Benoît Ranchoux, Sven Günther, Rozenn Quarck, Marie-Camille Chaumais, Peter Dorfmüller, Fabrice Antigny, Sébastien J Dumas, Nicolas Raymond, Edmund Lau, Laurent Savale,[...]. Am J Pathol 2015
101
9

Primary pulmonary hypertension. A national prospective study.
S Rich, D R Dantzker, S M Ayres, E H Bergofsky, B H Brundage, K M Detre, A P Fishman, R M Goldring, B M Groves, S K Koerner. Ann Intern Med 1987
9

Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models.
Frédéric Perros, Sven Günther, Benoit Ranchoux, Laurent Godinas, Fabrice Antigny, Marie-Camille Chaumais, Peter Dorfmüller, Aurélie Hautefort, Nicolas Raymond, Laurent Savale,[...]. Circulation 2015
80
9

Dasatinib in imatinib-resistant or -intolerant chronic-phase, chronic myeloid leukemia patients: 7-year follow-up of study CA180-034.
Neil P Shah, Philippe Rousselot, Charles Schiffer, Delphine Rea, Jorge E Cortes, Jorge Milone, Hesham Mohamed, Diane Healey, Hagop Kantarjian, Andreas Hochhaus,[...]. Am J Hematol 2016
100
9

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.
J E Cortes, D-W Kim, J Pinilla-Ibarz, P le Coutre, R Paquette, C Chuah, F E Nicolini, J F Apperley, H J Khoury, M Talpaz,[...]. N Engl J Med 2013
703
9

Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial.
Jorge E Cortes, Dong-Wook Kim, Javier Pinilla-Ibarz, Philipp D le Coutre, Ronald Paquette, Charles Chuah, Franck E Nicolini, Jane F Apperley, H Jean Khoury, Moshe Talpaz,[...]. Blood 2018
244
9

Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population.
Hannah Bower, Magnus Björkholm, Paul W Dickman, Martin Höglund, Paul C Lambert, Therese M-L Andersson. J Clin Oncol 2016
422
9

Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives.
Marc Humbert, Christophe Guignabert, Sébastien Bonnet, Peter Dorfmüller, James R Klinger, Mark R Nicolls, Andrea J Olschewski, Soni S Pullamsetti, Ralph T Schermuly, Kurt R Stenmark,[...]. Eur Respir J 2019
489
9

Reversal of experimental pulmonary hypertension by PDGF inhibition.
Ralph Theo Schermuly, Eva Dony, Hossein Ardeschir Ghofrani, Soni Pullamsetti, Rajkumar Savai, Markus Roth, Akylbek Sydykov, Ying Ju Lai, Norbert Weissmann, Werner Seeger,[...]. J Clin Invest 2005
782
8

Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia.
Hagop Kantarjian, Neil P Shah, Andreas Hochhaus, Jorge Cortes, Sandip Shah, Manuel Ayala, Beatriz Moiraghi, Zhixiang Shen, Jiri Mayer, Ricardo Pasquini,[...]. N Engl J Med 2010
8

Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitors.
Peter Valent, Emir Hadzijusufovic, Gerit-Holger Schernthaner, Dominik Wolf, Delphine Rea, Philipp le Coutre. Blood 2015
174
8

Reversible dasatinib-induced pulmonary arterial hypertension and right ventricle failure in a previously allografted CML patient.
D Mattei, M Feola, F Orzan, N Mordini, D Rapezzi, A Gallamini. Bone Marrow Transplant 2009
73
8

Pulmonary arterial hypertension exacerbated by ruxolitinib.
Andrew T Low, Luke Howard, Claire Harrison, Robert M R Tulloh. Haematologica 2015
29
17

Splenectomy and chronic thromboembolic pulmonary hypertension.
X Jaïs, V Ioos, C Jardim, O Sitbon, F Parent, A Hamid, E Fadel, P Dartevelle, G Simonneau, M Humbert. Thorax 2005
146
8

Updated clinical classification of pulmonary hypertension.
Gerald Simonneau, Michael A Gatzoulis, Ian Adatia, David Celermajer, Chris Denton, Ardeschir Ghofrani, Miguel Angel Gomez Sanchez, R Krishna Kumar, Michael Landzberg, Roberto F Machado,[...]. J Am Coll Cardiol 2013
8

Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.
Mark T Gladwin, Vandana Sachdev, Maria L Jison, Yukitaka Shizukuda, Jonathan F Plehn, Karin Minter, Bernice Brown, Wynona A Coles, James S Nichols, Inez Ernst,[...]. N Engl J Med 2004
883
8

Drug-induced pulmonary arterial hypertension: a recent outbreak.
David Montani, Andrei Seferian, Laurent Savale, Gérald Simonneau, Marc Humbert. Eur Respir Rev 2013
57
8

Dasatinib-induced pulmonary arterial hypertension.
Nurgül Özgür Yurttaş, Ahmet Emre Eşkazan. Br J Clin Pharmacol 2018
33
15

Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?
Kelly M Chin, Richard N Channick, Lewis J Rubin. Chest 2006
118
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.